Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Perfusion and diffusion MRI combined with ¹¹C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas.

Berntsson SG, Falk A, Savitcheva I, Godau A, Zetterling M, Hesselager G, Alafuzoff I, Larsson EM, Smits A.

J Neurooncol. 2013 Sep;114(2):241-9. doi: 10.1007/s11060-013-1178-3. Epub 2013 Jun 16.

2.

Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.

Kim YH, Oh SW, Lim YJ, Park CK, Lee SH, Kang KW, Jung HW, Chang KH.

Clin Neurol Neurosurg. 2010 Nov;112(9):758-65. doi: 10.1016/j.clineuro.2010.06.005. Epub 2010 Jul 8.

PMID:
20619531
3.

Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.

Sadeghi N, Salmon I, Tang BN, Denolin V, Levivier M, Wikler D, Rorive S, Balériaux D, Metens T, Goldman S.

J Magn Reson Imaging. 2006 Nov;24(5):989-94.

PMID:
17031832
4.

Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.

Tietze A, Boldsen JK, Mouridsen K, Ribe L, Dyve S, Cortnum S, Østergaard L, Borghammer P.

Acta Radiol. 2015 Sep;56(9):1135-44. doi: 10.1177/0284185114550020. Epub 2014 Sep 30.

PMID:
25270372
5.

Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.

Filss CP, Galldiks N, Stoffels G, Sabel M, Wittsack HJ, Turowski B, Antoch G, Zhang K, Fink GR, Coenen HH, Shah NJ, Herzog H, Langen KJ.

J Nucl Med. 2014 Apr;55(4):540-5. doi: 10.2967/jnumed.113.129007. Epub 2014 Feb 27.

6.

[Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].

Yamaguchi S, Terasaka S, Kobayashi H, Narita T, Hirata K, Shiga S, Usui R, Tanaka S, Kubota K, Murata J, Asaoka K.

No Shinkei Geka. 2010 Jul;38(7):621-8. Japanese.

PMID:
20628188
7.

Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation.

Roessler K, Gatterbauer B, Becherer A, Paul M, Kletter K, Prayer D, Hoeftberger R, Hainfellner J, Asenbaum S, Knosp E.

Minim Invasive Neurosurg. 2007 Oct;50(5):273-80.

PMID:
18058643
8.

Substitution of 11C-methionine PET by perfusion MRI during the follow-up of treated high-grade gliomas: preliminary results in clinical practice.

Dandois V, Rommel D, Renard L, Jamart J, Cosnard G.

J Neuroradiol. 2010 May;37(2):89-97. doi: 10.1016/j.neurad.2009.04.005. Epub 2009 Jun 30.

9.

11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.

Hatakeyama T, Kawai N, Nishiyama Y, Yamamoto Y, Sasakawa Y, Ichikawa T, Tamiya T.

Eur J Nucl Med Mol Imaging. 2008 Nov;35(11):2009-17. doi: 10.1007/s00259-008-0847-5. Epub 2008 Jun 10.

PMID:
18542957
10.

Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?

Weber MA, Henze M, Tüttenberg J, Stieltjes B, Meissner M, Zimmer F, Burkholder I, Kroll A, Combs SE, Vogt-Schaden M, Giesel FL, Zoubaa S, Haberkorn U, Kauczor HU, Essig M.

Invest Radiol. 2010 Dec;45(12):755-68. doi: 10.1097/RLI.0b013e3181ec9db0.

PMID:
20829706
11.

18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.

Jacobs AH, Thomas A, Kracht LW, Li H, Dittmar C, Garlip G, Galldiks N, Klein JC, Sobesky J, Hilker R, Vollmar S, Herholz K, Wienhard K, Heiss WD.

J Nucl Med. 2005 Dec;46(12):1948-58.

12.

Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.

Borbély K, Nyáry I, Tóth M, Ericson K, Gulyás B.

J Neurol Sci. 2006 Jul 15;246(1-2):85-94. Epub 2006 Mar 6.

PMID:
16603193
13.

11C-MET PET/CT and advanced MRI in the evaluation of tumor recurrence in high-grade gliomas.

D'Souza MM, Sharma R, Jaimini A, Panwar P, Saw S, Kaur P, Mondal A, Mishra A, Tripathi RP.

Clin Nucl Med. 2014 Sep;39(9):791-8. doi: 10.1097/RLU.0000000000000532.

PMID:
25036022
14.

[(18)F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas.

Collet S, Valable S, Constans JM, Lechapt-Zalcman E, Roussel S, Delcroix N, Abbas A, Ibazizene M, Bernaudin M, Barré L, Derlon JM, Guillamo JS.

Neuroimage Clin. 2015 May 29;8:448-54. doi: 10.1016/j.nicl.2015.05.012. eCollection 2015.

15.

Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.

Santarosa C, Castellano A, Conte GM, Cadioli M, Iadanza A, Terreni MR, Franzin A, Bello L, Caulo M, Falini A, Anzalone N.

Eur J Radiol. 2016 Jun;85(6):1147-56. doi: 10.1016/j.ejrad.2016.03.020. Epub 2016 Mar 22.

PMID:
27161065
16.

11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.

Gumprecht H, Grosu AL, Souvatsoglou M, Dzewas B, Weber WA, Lumenta CB.

Zentralbl Neurochir. 2007 Feb;68(1):19-23.

PMID:
17487804
17.

Evaluation of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid accumulation in low-grade glioma in chemically induced rat models: PET and autoradiography compared with morphological images and histopathological findings.

Doi Y, Kanagawa M, Maya Y, Tanaka A, Oka S, Nakata N, Toyama M, Matsumoto H, Shirakami Y.

Nucl Med Biol. 2015 Aug;42(8):664-72. doi: 10.1016/j.nucmedbio.2015.04.008. Epub 2015 May 7.

PMID:
26022202
18.

Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.

Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U.

Invest Radiol. 2013 May;48(5):295-301. doi: 10.1097/RLI.0b013e31827188d6.

PMID:
23296081
19.

Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas.

Takano K, Kinoshita M, Arita H, Okita Y, Chiba Y, Kagawa N, Fujimoto Y, Kishima H, Kanemura Y, Nonaka M, Nakajima S, Shimosegawa E, Hatazawa J, Hashimoto N, Yoshimine T.

AJNR Am J Neuroradiol. 2016 Jan;37(1):44-50. doi: 10.3174/ajnr.A4460. Epub 2015 Sep 17.

20.

Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.

Rossi Espagnet MC, Romano A, Mancuso V, Cicone F, Napolitano A, Scaringi C, Minniti G, Bozzao A.

Br J Radiol. 2016 Oct;89(1066):20160476. doi: 10.1259/bjr.20160476. Epub 2016 Aug 9.

PMID:
27505026

Supplemental Content

Support Center